Literature DB >> 16751768

The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection.

Milan Chromek1, Zuzana Slamová, Peter Bergman, László Kovács, L'udmila Podracká, Ingrid Ehrén, Tomas Hökfelt, Gudmundur H Gudmundsson, Richard L Gallo, Birgitta Agerberth, Annelie Brauner.   

Abstract

The urinary tract functions in close proximity to the outside environment, yet must remain free of microbial colonization to avoid disease. The mechanisms for establishing an antimicrobial barrier in this area are not completely understood. Here, we describe the production and function of the cathelicidin antimicrobial peptides LL-37, its precursor hCAP-18 and its ortholog CRAMP in epithelial cells of human and mouse urinary tract, respectively. Bacterial contact with epithelial cells resulted in rapid production and secretion of the respective peptides, and in humans LL-37/hCAP-18 was released into urine. Epithelium-derived cathelicidin substantially contributed to the protection of the urinary tract against infection, as shown using CRAMP-deficient and neutrophil-depleted mice. In addition, clinical E. coli strains that were more resistant to LL-37 caused more severe urinary tract infections than did susceptible strains. Thus, cathelicidin seems to be a key factor in mucosal immunity of the urinary tract.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751768     DOI: 10.1038/nm1407

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  245 in total

1.  The POU transcription factor Drifter/Ventral veinless regulates expression of Drosophila immune defense genes.

Authors:  Anna Junell; Hanna Uvell; Monica M Davis; Esther Edlundh-Rose; Asa Antonsson; Leslie Pick; Ylva Engström
Journal:  Mol Cell Biol       Date:  2010-05-10       Impact factor: 4.272

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

3.  Signaling pathways mediating chemokine induction in keratinocytes by cathelicidin LL-37 and flagellin.

Authors:  Anastasia Nijnik; Jelena Pistolic; Niall C J Filewod; Robert E W Hancock
Journal:  J Innate Immun       Date:  2012-04-17       Impact factor: 7.349

Review 4.  Antimicrobial anxiety: the impact of stress on antimicrobial immunity.

Authors:  Katherine A Radek
Journal:  J Leukoc Biol       Date:  2010-05-04       Impact factor: 4.962

Review 5.  Epithelial antimicrobial defence of the skin and intestine.

Authors:  Richard L Gallo; Lora V Hooper
Journal:  Nat Rev Immunol       Date:  2012-06-25       Impact factor: 53.106

Review 6.  NGAL-Siderocalin in kidney disease.

Authors:  Neal Paragas; Andong Qiu; Maria Hollmen; Thomas L Nickolas; Prasad Devarajan; Jonathan Barasch
Journal:  Biochim Biophys Acta       Date:  2012-06-19

Review 7.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

8.  A bacterial pathogen co-opts host plasmin to resist killing by cathelicidin antimicrobial peptides.

Authors:  Andrew Hollands; David Gonzalez; Emma Leire; Cortny Donald; Richard L Gallo; Martina Sanderson-Smith; Pieter C Dorrestein; Victor Nizet
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

Review 9.  The nature of immune responses to urinary tract infections.

Authors:  Soman N Abraham; Yuxuan Miao
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

10.  Influence of biofilms on morbidity associated with short-term indwelling ureteral stents: a prospective observational study.

Authors:  Patrick Betschart; Valentin Zumstein; Matthias T Buhmann; Werner C Albrich; Oliver Nolte; Sabine Güsewell; Hans-Peter Schmid; Qun Ren; Dominik Abt
Journal:  World J Urol       Date:  2018-11-27       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.